Long-acting injectable drugs for HIV-1 pre-exposure prophylaxis: considerations for Africa
E Moyo, G Murewanhema, G Musuka… - Tropical Medicine and …, 2022 - mdpi.com
Sub-Saharan Africa carries the highest burden of HIV-1 and AIDS. About 39% of all new
infections in the world in 2020 were in this region. Oral PrEP was found to be very effective …
infections in the world in 2020 were in this region. Oral PrEP was found to be very effective …
Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives
S Mahomed - Clinical Microbiology Reviews, 2024 - Am Soc Microbiol
The human immunodeficiency virus (HIV) epidemic remains a formidable global health
concern, with 39 million people living with the virus and 1.3 million new infections reported …
concern, with 39 million people living with the virus and 1.3 million new infections reported …
Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: results from a …
JD Tapsoba, J Cover, C Obong'o, M Brady… - Plos …, 2022 - journals.plos.org
Background In sub-Saharan Africa (SSA), adolescent girls and young women (AGYW) ages
15 to 24 years represent< 10% of the population yet account for 1 in 5 new HIV infections …
15 to 24 years represent< 10% of the population yet account for 1 in 5 new HIV infections …
Preferences and acceptability for long‐acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya
NJ Wara, R Mvududu, MM Marwa… - Journal of the …, 2023 - Wiley Online Library
Introduction Long‐acting pre‐exposure prophylaxis (PrEP) options could overcome barriers
to oral PrEP persistence during pregnancy and postpartum. We evaluated long‐acting PrEP …
to oral PrEP persistence during pregnancy and postpartum. We evaluated long‐acting PrEP …
Uptake of a patient‐centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE study
J Kabami, E Kakande, G Chamie… - Journal of the …, 2023 - Wiley Online Library
Introduction Person‐centred HIV prevention delivery models that offer structured choices in
product, testing and visit location may increase coverage. However, data are lacking on the …
product, testing and visit location may increase coverage. However, data are lacking on the …
[HTML][HTML] Stability and bifurcation analysis of an HIV model with pre-exposure prophylaxis and treatment interventions
Oral pre-exposure prophylaxis (PrEP) is a highly effective method of HIV prevention.
However, despite its effectiveness, the use of PrEP is not without challenges. These …
However, despite its effectiveness, the use of PrEP is not without challenges. These …
Integration of HIV pre-exposure prophylaxis (PrEP) services for pregnant and breastfeeding women in eight primary care clinics: results of an implementation science …
A Nelson, K Bheemraj, SS Dean, A de Voux… - BMC Global and Public …, 2024 - Springer
Background Although HIV vertical transmission has declined significantly in sub-Saharan
Africa, incident HIV infection in pregnant and postpartum women is estimated to account for …
Africa, incident HIV infection in pregnant and postpartum women is estimated to account for …
Centring the health of women across the HIV research continuum
E Barr, LJ Marshall, LF Collins, C Godfrey, N St Vil… - The Lancet …, 2024 - thelancet.com
Despite tremendous advances in HIV research, women and gender diverse people—
particularly women from racial and ethnic groups under-represented in research …
particularly women from racial and ethnic groups under-represented in research …
The importance of assessing and addressing mental health barriers to PrEP use during pregnancy and postpartum in sub‐Saharan Africa: state of the science and …
Introduction: Pregnant and postpartum women (PPW) in sub-Saharan Africa are at
disproportionately high risk of HIV infection compared to non-pregnant women. When used …
disproportionately high risk of HIV infection compared to non-pregnant women. When used …
Safety surveillance for PrEP in pregnant and breastfeeding women
The risk of HIV acquisition is higher during pregnancy and postpartum than other times.
Newly acquired maternal HIV infection associated with high primary viraemia, substantially …
Newly acquired maternal HIV infection associated with high primary viraemia, substantially …